ABT-436 for Alcohol Dependence

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
The primary efficacy endpoint examines the hypothesis that ABT-436 will decrease the weekly percentage of heavy drinking days during Study Weeks 2 through 12 (Days 8-84) as compared to placebo. A \"heavy drinking day\" is 4 or more drinks per drinking day for women and 5 or more drinks per drinking day for men.
Epistemonikos ID: d1edb79727cc1a5f76feb072c31786df5a97bc02
First added on: May 11, 2024